Health Care Option (NASDAQ: OPCH) was upgraded by equity researchers at TheStreet from a “c +” rating to a “b” rating in a report released Thursday, TheStreetRatingsTable reports.
Other stock analysts have also recently published research reports on the company. Deutsche Bank Aktiengesellschaft raised its price target on Option Care Health from $ 23.50 to $ 32.00 and gave the stock a “buy” rating in a research report published on Friday, November 5. Zacks Investment Research downgraded Option Care Health’s rating from a “buy” rating to a “keep” rating in a research report released on Tuesday, November 9. Finally, Lake Street Capital raised its price target on Option Care Health from $ 27.00 to $ 35 and gave the company a “buy” rating in a research report published on Monday, August 30. One research analyst rated the stock with a conservation rating and six assigned a buy rating to the company’s stock. According to MarketBeat data, Option Care Health currently has a consensus rating of “Buy” and a consensus target price of $ 27.75.
Option Care Health stock opened at $ 25.70 on Thursday. The company has a debt to equity ratio of 1.02, a quick ratio of 1.28 and a current ratio of 1.67. The stock has a fifty-day moving average of $ 25.82 and a two-hundred-day moving average of $ 23.30. The company has a market cap of $ 4.62 billion, a price-to-earnings ratio of 55.87 and a beta of 1.33. Option Care Health has a 52 week low of $ 14.31 and a 52 week high of $ 28.59.
Option Care Health (NASDAQ: OPCH) last released its quarterly results on Thursday, November 4. The company reported earnings per share of $ 0.20 for the quarter, beating the consensus estimate of $ 0.19 by $ 0.01. The company posted revenue of $ 891.94 million in the quarter, compared to a consensus estimate of $ 886.47 million. Option Care Health recorded a return on equity of 7.86% and a net margin of 2.48%. Option Care Health revenues increased 14.1% compared to the same quarter last year. In the same quarter of last year, the company posted earnings per share of $ 0.01. On average, analysts expect Option Care Health to post 0.6 EPS for the current fiscal year.
Meanwhile, COO Harriet Booker sold 6,000 Option Care Health shares in a trade on Monday, December 6. The stock was sold for an average price of $ 24.81, for a total value of $ 148,860.00. The sale was disclosed in a legal file with the SEC, which can be accessed through this hyperlink. 47.00% of the shares are held by insiders.
Institutional investors recently changed their holdings of equities. Royal Bank of Canada increased its stake in Option Care Health shares by 86.4% during the first quarter. Royal Bank of Canada now owns 13,278 shares of the company valued at $ 235,000 after purchasing an additional 6,153 shares in the last quarter. Principal Financial Group Inc. increased its stake in Option Care Health shares by 19.7% during the first quarter. Principal Financial Group Inc. now owns 59,101 shares of the company valued at $ 1,048,000 after purchasing an additional 9,723 shares in the last quarter. Alliancebernstein LP increased its stake in Option Care Health shares by 9.3% in the second quarter. Alliancebernstein LP now owns 129,900 shares of the company valued at $ 2,841,000 after purchasing an additional 11,100 shares in the last quarter. Trustcore Financial Services LLC increased its stake in Option Care Health shares by 33.3% during the second quarter. Trustcore Financial Services LLC now owns 2,000 shares of the company valued at $ 44,000 after purchasing an additional 500 shares in the last quarter. Finally, Advisor Group Holdings Inc. increased its stake in Option Care Health shares by 110.0% during the second quarter. Advisor Group Holdings Inc. now owns 3,561 shares of the company valued at $ 78,000 after purchasing an additional 1,865 shares in the last quarter. Hedge funds and other institutional investors hold 79.03% of the company’s shares.
About Option Care Santé
Option Care Health, Inc is committed to the provision of home and alternative site infusion services. The practice is responsible for the clinical management of infusion therapy, nursing support and coordination of care. It also offers anti-infective, nutritional support, heart failure, chronic inflammatory disorders, immunoglobulin, bleeding disorders, women’s health, neurological disorders and specialty therapies.
Featured article: What is a bull market?
This instant news alert was powered by storytelling technology and financial data from MarketBeat to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team before publication. Please send any questions or comments about this story to [email protected]
Should you invest $ 1,000 in Option Care Health now?
Before you consider Option Care Health, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks that top analysts quietly whisper to their clients to buy now before the broader market takes hold of… and Option Care Health was not on the list.
While Option Care Health currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better bets.
See the 5 actions here